← Eichor
Condition: Parathyroid Gland Adenoma Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Parathyroid Gland Adenoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

99mTc Sestamibi SPECT/CT vs 18F Fluorocholine PET/CT
Phase 2/Phase 3 · 1 location(s) · Andrei Iagaru · NCT05891769
Institution of an Italian Multicenter Database of Patients with Parathyroid Carcinoma or Atypical Parathyroid Adenoma
Phase N/A · 33 location(s) · F.I.R.M.O. - Fondazione Italiana Ricerca sulle Malattie dell · NCT06645951
Accuracy of 18F-Fluorocholine PET/MR and NeuroEXPLORER PET/CT Imaging for Localization of Parathyroid Tumors
Phase 2/Phase 3 · 1 location(s) · National Institute of Diabetes and Digestive and Kidney Dise · NCT07444723
PTeye in Parathyroid Adenoma
Phase N/A · 1 location(s) · Aristotle University Of Thessaloniki · NCT06913296
Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients
Phase N/A · 3 location(s) · Universidad Nacional Autonoma de Mexico · NCT06523582
High-resolution PET-CT Specimen Imaging for the Perioperative Visualization of Resection Margins
NA · 1 location(s) · Algemeen Ziekenhuis Maria Middelares · NCT06835426
Agnostic Therapy in Rare Solid Tumors
Phase 2 · 8 location(s) · Instituto do Cancer do Estado de São Paulo · NCT06638931
Molecular and Immunohistochemical Profiling of Tumors in Patients With Parathyroid Tumors
Phase N/A · 1 location(s) · M.D. Anderson Cancer Center · NCT03039439
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.